A Study to Compare the Pharmacokinetics and Safety of QL1101 and EU-Avastin® in Healthy Volunteers
Clinical trial NCT06232902 · COMPLETED
Trial details
- NCT number
- NCT06232902
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-20
- Primary completion
- 2024-11-18
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.